A detailed history of Thrivent Financial For Lutherans transactions in Illumina, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 61,749 shares of ILMN stock, worth $8.08 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
61,749
Previous 60,298 2.41%
Holding current value
$8.08 Million
Previous $6.29 Million 27.93%
% of portfolio
0.02%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$105.28 - $135.9 $152,761 - $197,190
1,451 Added 2.41%
61,749 $8.05 Million
Q2 2024

Aug 13, 2024

BUY
$101.05 - $133.57 $3 Million - $3.97 Million
29,709 Added 97.12%
60,298 $6.29 Million
Q1 2024

May 14, 2024

BUY
$127.73 - $147.2 $1.07 Million - $1.23 Million
8,346 Added 37.52%
30,589 $4.2 Million
Q4 2023

Feb 14, 2024

BUY
$92.79 - $142.53 $1.42 Million - $2.18 Million
15,299 Added 220.32%
22,243 $3.1 Million
Q3 2023

Nov 14, 2023

SELL
$128.91 - $192.44 $9,797 - $14,625
-76 Reduced 1.08%
6,944 $953,000
Q2 2023

Aug 14, 2023

SELL
$183.43 - $232.67 $10,638 - $13,494
-58 Reduced 0.82%
7,020 $1.32 Million
Q1 2023

May 17, 2023

SELL
$193.75 - $232.55 $17,631 - $21,162
-91 Reduced 1.27%
7,078 $1.65 Million
Q4 2022

Feb 08, 2023

BUY
$187.24 - $242.74 $33,328 - $43,207
178 Added 2.55%
7,169 $1.45 Million
Q3 2022

Nov 14, 2022

SELL
$177.23 - $227.44 $200,978 - $257,916
-1,134 Reduced 13.96%
6,991 $1.33 Million
Q2 2022

Aug 16, 2022

SELL
$181.58 - $368.0 $523,131 - $1.06 Million
-2,881 Reduced 26.18%
8,125 $1.5 Million
Q1 2022

May 13, 2022

SELL
$303.87 - $423.8 $4.3 Million - $6 Million
-14,155 Reduced 56.26%
11,006 $3.85 Million
Q4 2021

Feb 16, 2022

SELL
$347.28 - $421.83 $23.3 Million - $28.3 Million
-67,112 Reduced 72.73%
25,161 $9.62 Million
Q3 2021

Nov 15, 2021

BUY
$405.61 - $524.84 $18.7 Million - $24.2 Million
46,107 Added 99.87%
92,273 $37.4 Million
Q2 2021

Sep 24, 2021

BUY
$372.84 - $481.5 $172,997 - $223,416
464 Added 1.02%
46,166 $21.8 Million
Q2 2021

Aug 19, 2021

SELL
$372.84 - $481.5 $445,916 - $575,874
-1,196 Reduced 2.55%
45,702 $21.6 Million
Q1 2021

May 17, 2021

BUY
$361.28 - $504.76 $13.6 Million - $19 Million
37,601 Added 404.44%
46,898 $18 Million
Q4 2020

Feb 16, 2021

BUY
$292.7 - $370.96 $722,969 - $916,271
2,470 Added 36.18%
9,297 $3.44 Million
Q3 2020

Nov 10, 2020

SELL
$268.51 - $400.74 $688,459 - $1.03 Million
-2,564 Reduced 27.3%
6,827 $2.11 Million
Q2 2020

Aug 12, 2020

BUY
$256.46 - $373.01 $215,682 - $313,701
841 Added 9.84%
9,391 $3.48 Million
Q1 2020

May 15, 2020

SELL
$209.2 - $335.53 $45.3 Million - $72.6 Million
-216,319 Reduced 96.2%
8,550 $2.34 Million
Q4 2019

Feb 13, 2020

SELL
$288.29 - $335.49 $10.8 Million - $12.6 Million
-37,469 Reduced 14.28%
224,869 $74.6 Million
Q3 2019

Nov 14, 2019

BUY
$266.84 - $378.23 $5.87 Million - $8.32 Million
21,991 Added 9.15%
262,338 $79.8 Million
Q2 2019

Aug 13, 2019

SELL
$300.59 - $368.15 $1.39 Million - $1.7 Million
-4,622 Reduced 1.89%
240,347 $88.5 Million
Q1 2019

May 14, 2019

BUY
$272.57 - $321.18 $20.4 Million - $24 Million
74,809 Added 43.96%
244,969 $76.1 Million
Q4 2018

Feb 15, 2019

BUY
$272.46 - $366.54 $557,180 - $749,574
2,045 Added 1.22%
170,160 $51 Million
Q3 2018

Nov 15, 2018

SELL
$279.04 - $367.06 $676,951 - $890,487
-2,426 Reduced 1.42%
168,115 $61.7 Million
Q2 2018

Aug 14, 2018

BUY
$228.17 - $292.07 $37.5 Million - $48 Million
164,448 Added 2698.97%
170,541 $47.6 Million
Q1 2018

May 08, 2018

BUY
$209.54 - $253.91 $34,364 - $41,641
164 Added 2.77%
6,093 $1.44 Million
Q4 2017

Feb 14, 2018

BUY
$202.23 - $230.03 $30,132 - $34,274
149 Added 2.58%
5,929 $1.3 Million
Q3 2017

Nov 14, 2017

BUY
$172.3 - $213.93 $995,894 - $1.24 Million
5,780
5,780 $1.15 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $20.6B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.